Literature DB >> 21641103

Maternal angiogenic profile in pregnancies that remain normotensive.

Jessica M Faupel-Badger1, Anne Cathrine Staff, Ravi Thadhani, Camille E Powe, Nancy Potischman, Robert N Hoover, Rebecca Troisi.   

Abstract

OBJECTIVE: We sought to determine if maternal characteristics are associated with angiogenic profile in the first and second trimester of normotensive pregnancies. STUDY
DESIGN: Circulating levels of maternal placental like growth factor (PlGF), soluble fms-like tyrosine kinase receptor (sFlt1), and soluble endoglin (sEng) were measured in serum samples collected during the first (median 11.3 weeks) and second trimester (median 17.1 weeks) of 182 normotensive pregnancies. Diastolic blood pressure (DBP), systolic blood pressure (SBP), and mean arterial pressure (MAP) were measured at the same visits when samples were collected to measure angiogenic factors. Linear regression analysis was used to examine associations of the angiogenic measures with maternal characteristics. The association between blood pressure measures and concentrations of angiogenic factors was evaluated using Spearman correlation and linear regression analysis.
RESULTS: In adjusted analyses, nulliparous women had higher sFlt1 concentrations in both first (p=0.06) and second (p=0.001) trimester. Higher BMI was associated with greater sFlt1 concentrations in both the first (p=0.004) and second trimester (p=0.008), but significantly lower sEng concentrations in both trimesters (p=0.002 for first trimester and p=0.0009 for second). Nulliparity and higher BMI also were associated with higher sFlt1/PLGF anti-angiogenic ratios in both first (p=0.05 and p=0.007, respectively) and second trimesters (p=0.003 and p=0.02, respectively). First trimester sFlt1 levels were weakly correlated with first trimester SBP (r(s)=0.18, p=0.03) and MAP (r(s)=0.16, p=0.04). Second trimester sEng levels were inversely associated with second trimester MAP (r(s)=-0.17, p=0.05). Including blood pressure measures in the linear regression models did not change the reported associations of angiogenic factors with maternal characteristics.
CONCLUSIONS: These results demonstrate that even early in normotensive pregnancies maternal characteristics are associated with variations in angiogenic profile across this population. Published by Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21641103      PMCID: PMC3302581          DOI: 10.1016/j.ejogrb.2011.05.001

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  25 in total

Review 1.  Risk factors for preeclampsia.

Authors:  G A Dekker
Journal:  Clin Obstet Gynecol       Date:  1999-09       Impact factor: 2.190

2.  Pulse pressure and risk of preeclampsia: a prospective study.

Authors:  R Thadhani; J L Ecker; E Kettyle; L Sandler; F D Frigoletto
Journal:  Obstet Gynecol       Date:  2001-04       Impact factor: 7.661

3.  First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.

Authors:  Ravi Thadhani; Walter P Mutter; Myles Wolf; Richard J Levine; Robert N Taylor; Vikas P Sukhatme; Jeffrey Ecker; S Ananth Karumanchi
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

Review 4.  Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregnancy.

Authors:  P Kaufmann; T M Mayhew; D S Charnock-Jones
Journal:  Placenta       Date:  2004 Feb-Mar       Impact factor: 3.481

5.  Midpregnancy levels of angiogenic markers in relation to maternal characteristics.

Authors:  Renée S Mijal; Claudia B Holzman; Sarosh Rana; S Ananth Karumanchi; Jianling Wang; Alla Sikorskii
Journal:  Am J Obstet Gynecol       Date:  2010-12-10       Impact factor: 8.661

6.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States).

Authors:  Rebecca Troisi; Nancy Potischman; James Roberts; Pentti Siiteri; Ashi Daftary; Cynthia Sims; Robert N Hoover
Journal:  Cancer Causes Control       Date:  2003-05       Impact factor: 2.506

8.  Differential risk of hypertensive disorders of pregnancy among Hispanic women.

Authors:  Myles Wolf; Anand Shah; Ricardo Jimenez-Kimble; Jenny Sauk; Jeffrey L Ecker; Ravi Thadhani
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

9.  Circulating angiogenic factors and the risk of preeclampsia.

Authors:  Richard J Levine; Sharon E Maynard; Cong Qian; Kee-Hak Lim; Lucinda J England; Kai F Yu; Enrique F Schisterman; Ravi Thadhani; Benjamin P Sachs; Franklin H Epstein; Baha M Sibai; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  N Engl J Med       Date:  2004-02-05       Impact factor: 91.245

10.  How does smoking reduce the risk of preeclampsia?

Authors:  S Ananth Karumanchi; Richard J Levine
Journal:  Hypertension       Date:  2010-03-15       Impact factor: 10.190

View more
  8 in total

Review 1.  Epidemiology of preeclampsia: impact of obesity.

Authors:  Arun Jeyabalan
Journal:  Nutr Rev       Date:  2013-10       Impact factor: 7.110

2.  Performance of sFlt-1/PIGF Ratio for the Prediction of Perinatal Outcome in Obese Pre-Eclamptic Women.

Authors:  Anne Karge; Linus Desing; Bernhard Haller; Javier U Ortiz; Silvia M Lobmaier; Bettina Kuschel; Oliver Graupner
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

3.  Racial-ethnic differences in midtrimester maternal serum levels of angiogenic and antiangiogenic factors.

Authors:  Juan Yang; Michelle Pearl; Gerald N DeLorenze; Roberto Romero; Zhong Dong; Laura Jelliffe-Pawlowski; Robert Currier; Monica Flessel; Martin Kharrazi
Journal:  Am J Obstet Gynecol       Date:  2016-04-09       Impact factor: 8.661

4.  Circulating angiogenic factors and risk of adverse maternal and perinatal outcomes in twin pregnancies with suspected preeclampsia.

Authors:  Sarosh Rana; Michele R Hacker; Anna Merport Modest; Saira Salahuddin; Kee-Hak Lim; Stefan Verlohren; Frank H Perschel; S Ananth Karumanchi
Journal:  Hypertension       Date:  2012-07-02       Impact factor: 10.190

5.  Prediction of twin pregnancy preeclampsia based on clinical risk factors, early pregnancy serum markers, and uterine artery pulsatility index.

Authors:  Yan Lu; Zhongying Ding; Wenwen Li; Lina Mei; Linglong Shen; Huaying Shan
Journal:  Pak J Med Sci       Date:  2021 Nov-Dec       Impact factor: 1.088

6.  Novel Early Pregnancy Multimarker Screening Test for Preeclampsia Risk Prediction.

Authors:  Kaspar Ratnik; Kristiina Rull; Oliver Aasmets; Triin Kikas; Ele Hanson; Kalle Kisand; Krista Fischer; Maris Laan
Journal:  Front Cardiovasc Med       Date:  2022-07-27

Review 7.  What are the metabolic precursors which increase the risk of pre-eclampsia and how could these be investigated further.

Authors:  Jenny E Myers
Journal:  Placenta       Date:  2017-08-24       Impact factor: 3.481

8.  Circulating soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor during pregnancy in normotensive women in KwaZulu-Natal, South Africa.

Authors:  Muhammed Ogunlola; Poovendhree Reddy; Maureen N Sibiya; Laura O'Connor; Dorinda Borg; Firoza Haffejee; Shanaz Ghuman; Thembelihle Ngxongo; Nalini Govender
Journal:  Afr Health Sci       Date:  2019-06       Impact factor: 0.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.